$39.14
-0.31%Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company's Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs. The company was founded in 2003 and is based in Atlanta, Georgia.
Thin margins leave little room for error. Cost management and pricing strategy are critical.
Acceptable margins but limited operational leverage. Operating expense control is important.
Minimal profitability after all expenses. Limited financial flexibility for reinvestment or shareholder returns.
Higher tax burden may reflect limited tax optimization or operations in high-tax jurisdictions.
Efficient profit conversion: Minimal margin compression from gross to net indicates lean operations and favorable tax/interest environment.
GRDN • NYSE
| Guardian Pharmacy Services, Inc. Income Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 |
|---|---|---|---|---|---|---|---|---|
REVENUE | ||||||||
1.4B | 1.2B | 1B | 908.9M | 792.1M | 736M | 698.3M | 600.4M | |
GROSS PROFIT | ||||||||
(1.2B) | (984M) | (837.9M) | (723M) | (630.8M) | (589M) | (554.8M) | (477.3M) | |
282M | 244.4M | 208.3M | 185.9M | 161.3M | 147M | 143.5M | 123M | |
OPERATING INCOME | ||||||||
(193.1M) | (307.3M) | (167.4M) | (133.9M) | (131.1M) | (114.9M) | (109.4M) | (97.1M) | |
(220M) | (307.3M) | (167.4M) | (133.9M) | (131.1M) | (102.5M) | (97.6M) | (87.8M) | |
88.9M | -62.9M | 40.9M | 52M | 30.2M | 32.1M | 34.1M | 25.9M | |
PRE-TAX INCOME | ||||||||
(665K) | (3.3M) | (2.9M) | (1.9M) | (1.6M) | (2.2M) | (2.3M) | (1.9M) | |
-665K | -3.3M | -2.9M | -1.9M | -1.6M | -2.2M | -2.3M | -1.9M | |
-26.9M | (0.0) | (0.0) | (0.0) | (0.0) | (12.4M) | (11.8M) | (9.3M) | |
-15.5M | -3.6M | -3.2M | -2.3M | -1.8M | -2.4M | -2.7M | -2.7M | |
73.4M | -66.5M | 37.7M | 49.7M | 28.3M | 29.7M | 31.4M | 23.3M | |
NET INCOME | ||||||||
(24.5M) | (4.6M) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | |
49.2M | -87.3M | 23.9M | 35.4M | 16.3M | 19.9M | 21.7M | 14.7M |
GRDN - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K 8-K 2026 N/A | May 28, 2026 | May 21, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 07, 2026 | May 05, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | May 06, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 06, 2026 | May 06, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | March 26, 2026 | May 05, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 23, 2026 | March 18, 2026 | 2026 | |
10-K 10-K 2025 FY FY | March 11, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | March 11, 2026 | March 11, 2026 | 2026 | |
8-K 8-K 2026 N/A | January 13, 2026 | January 13, 2026 | 2026 | |
8-K 8-K 2025 N/A | November 10, 2025 | November 10, 2025 | 2025 |
Continue your GRDN research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.